(VIANEWS) – Afya (AFYA), Insteel Industries (IIIN), Installed Building Products (IBP) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Afya (AFYA)

45.7% sales growth and 12.45% return on equity

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil.

Afya’s sales growth this year is expected to be 39.2% and 24.7% for next year.

Year-on-year quarterly revenue growth grew by 56.3%, now sitting on 1.2B for the twelve trailing months.

Volume

Today’s last reported volume for Afya is 30401 which is 85.13% below its average volume of 204469.

Afya’s sales growth for the next quarter is 45.7%. The company’s growth estimates for the present quarter and the next is 50% and 50%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.45%.

Volatility

Afya’s last day, last week, and last month’s current volatility was 2.65%, 2.11%, and 1.74%, respectively.

Afya’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.32% (day), 3.54% (last week), and 3.52% (last month), respectively.

Afya’s Stock Yearly Top and Bottom Value

Afya’s stock is valued at $25.31 at 02:22 EST, way under its 52-week high of $29.01 and way above its 52-week low of $18.48.

Afya’s Moving Average

Afya’s worth is below its 50-day moving average of $25.71 and above its 200-day moving average of $23.31.

2. Insteel Industries (IIIN)

24.3% sales growth and 14.58% return on equity

Insteel Industries, Inc., together with its subsidiaries, manufactures and markets steel wire reinforcing products for concrete construction applications.

Insteel Industries’s sales growth this year is expected to be 23.9% and 7.6% for next year.

Year-on-year quarterly revenue growth grew by 21%, now sitting on 518.79M for the twelve trailing months.

Volume

Today’s last reported volume for Insteel Industries is 58147 which is 46.42% below its average volume of 108533.

Insteel Industries’s sales growth is a negative 0% for the current quarter and 24.3% for the next. The company’s growth estimates for the ongoing quarter and the next is 100% and 68.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.58%.

Volatility

Insteel Industries’s last day, last week, and last month’s current volatility was 0.30%, 1.10%, and 2.09%, respectively.

Insteel Industries’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.39% (day), 3.26% (last week), and 3.43% (last month), respectively.

Insteel Industries’s Stock Yearly Top and Bottom Value

Insteel Industries’s stock is valued at $33.45 at 02:22 EST, way below its 52-week high of $41.66 and way higher than its 52-week low of $16.81.

Insteel Industries’s Moving Average

Insteel Industries’s value is higher than its 50-day moving average of $33.02 and above its 200-day moving average of $32.04.

3. Installed Building Products (IBP)

21.3% sales growth and 33.61% return on equity

Installed Building Products, Inc., together with its subsidiaries, engages in the installation of insulation, waterproofing, fire-stopping, fireproofing, garage doors, rain gutters, window blinds, shower doors, closet shelving and mirrors, and other products in the continental United States.

Installed Building Products’s sales growth this year is expected to be 17.8% and 10.8% for next year.

Year-on-year quarterly revenue growth grew by 10%, now sitting on 1.69B for the twelve trailing months.

Volume

Today’s last reported volume for Installed Building Products is 91585 which is 64.96% below its average volume of 261390.

Installed Building Products’s sales growth for the next quarter is 21.3%. The company’s growth estimates for the present quarter and the next is 31.2% and 39.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 33.61%.

Volatility

Installed Building Products’s last day, last week, and last month’s current volatility was 2.46%, 1.27%, and 2.33%, respectively.

Installed Building Products’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.96% (day), 2.80% (last week), and 3.31% (last month), respectively.

Installed Building Products’s Stock Yearly Top and Bottom Value

Installed Building Products’s stock is valued at $112.89 at 02:22 EST, way below its 52-week high of $140.58 and way higher than its 52-week low of $73.66.

Installed Building Products’s Moving Average

Installed Building Products’s value is below its 50-day moving average of $117.15 and below its 200-day moving average of $117.40.

4. Pro-Dex (PDEX)

10.3% sales growth and 27% return on equity

Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide.

Pro-Dex’s sales growth this year is expected to be 12% and 7.7% for next year.

Year-on-year quarterly revenue growth grew by 3.8%, now sitting on 36.49M for the twelve trailing months.

Volume

Today’s last reported volume for Pro-Dex is 45539 which is 156.14% above its average volume of 17779.

Pro-Dex’s sales growth for the next quarter is 10.3%. The company’s growth estimates for the ongoing quarter and the next is a negative 54.7% and 12.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27%.

Volatility

Pro-Dex’s last day, last week, and last month’s current volatility was 0.23%, 1.70%, and 2.28%, respectively.

Pro-Dex’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.38% (day), 3.79% (last week), and 5.03% (last month), respectively.

Pro-Dex’s Stock Yearly Top and Bottom Value

Pro-Dex’s stock is valued at $29.25 at 02:22 EST, way under its 52-week high of $42.60 and way higher than its 52-week low of $18.29.

Pro-Dex’s Moving Average

Pro-Dex’s worth is under its 50-day moving average of $31.34 and above its 200-day moving average of $29.13.

5. LHC Group (LHCG)

8.9% sales growth and 9.52% return on equity

LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States.

LHC Group’s sales growth this year is expected to be 8.8% and 9.1% for next year.

Year-on-year quarterly revenue growth grew by 2.3%, now sitting on 2.08B for the twelve trailing months.

Volume

Today’s last reported volume for LHC Group is 155058 which is 3.96% below its average volume of 161458.

LHC Group’s sales growth for the next quarter is 8.9%. The company’s growth estimates for the present quarter and the next is 26% and 4.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.52%.

Volatility

LHC Group’s last day, last week, and last month’s current volatility was 1.75%, 1.04%, and 1.51%, respectively.

LHC Group’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.63% (day), 2.10% (last week), and 3.11% (last month), respectively.

LHC Group’s Stock Yearly Top and Bottom Value

LHC Group’s stock is valued at $203.35 at 02:22 EST, way under its 52-week high of $236.81 and way above its 52-week low of $170.01.

LHC Group’s Moving Average

LHC Group’s value is above its 50-day moving average of $202.16 and higher than its 200-day moving average of $201.21.

6. Novo Nordisk A/S (NVO)

7.2% sales growth and 75.94% return on equity

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide.

Novo Nordisk A/S’s sales growth this year is expected to be 7.1% and 7% for next year.

Year-on-year quarterly revenue growth declined by 0.2%, now sitting on 126.88B for the twelve trailing months.

Volume

Today’s last reported volume for Novo Nordisk A/S is 869071 which is 0.32% below its average volume of 871834.

Novo Nordisk A/S’s sales growth for the next quarter is 7.2%. The company’s growth estimates for the present quarter and the next is 6.9% and 5.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 75.94%.

Volatility

Novo Nordisk A/S’s last day, last week, and last month’s current volatility was 0.77%, 0.38%, and 0.61%, respectively.

Novo Nordisk A/S’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.69% (day), 1.00% (last week), and 0.99% (last month), respectively.

Novo Nordisk A/S’s Stock Yearly Top and Bottom Value

Novo Nordisk A/S’s stock is valued at $88.66 at 02:22 EST, above its 52-week high of $86.64.

Novo Nordisk A/S’s Moving Average

Novo Nordisk A/S’s value is higher than its 50-day moving average of $82.35 and way above its 200-day moving average of $74.50.

LEAVE A REPLY

Please enter your comment!
Please enter your name here